Citrate versus unfractionated heparin for anticoagulation in continuous renal replacement therapy

Chinese Medical Journal

Volumn 126, Issue 7, 2013, Pages 1344-1349

  Liao, Yu Jie ^a   Zhang, Ling ^a   Zeng, Xiao Xi ^a   Fu, Ping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Anticoagulation; Citrate; Continuous renal replacement therapy; Meta analysis; Unfractionated heparin

Indexed keywords

CITRIC ACID; HEPARIN;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; ANTICOAGULATION; ARTICLE; BIBLIOGRAPHIC DATABASE; BLEEDING; CHINA NATIONAL KNOWLEDGE INFRASTRUCTURE DATABASE; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; DATA EXTRACTION; DISEASE SPECIFIC SURVIVAL; EMBASE; HOMEOSTASIS; HUMAN; HYPOCALCEMIA; MEDLINE; META ANALYSIS (TOPIC); METABOLIC DISORDER; OUTCOME ASSESSMENT; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRANSFUSION; UREMIA;

ANTICOAGULANTS; CITRIC ACID; HEPARIN; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL REPLACEMENT THERAPY;

EID: 84877349579     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20121179     Document Type: Article

References (25)

1. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, et al. Continuous renal replacement therapy: a worldwide practice survey. The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Intensive Care Med 2007; 33: 1563-1570.
2. Tolwani AJ, Wille KM. Anticoagulation for continuous renal replacement therapy. Semin Dial 2009; 22: 141-145.
3. Davies H, Leslie G. Anticoagulation in CRRT: agents and strategies in Australian ICUs. Aust Crit Care 2007; 20: 15-26.
4. van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JMD, Chang PC. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996; l7: 145-150.
5. Davenport A, Will EJ, Davison AM. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute and hepatic failure. Nephron 1994; 66: 431-437.
6. Martin PY, Chevrolet JC, Suter P, Favre H. Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. Am J Kidney Dis 1994; 24: 806-812.
7. Menajovsky LB. Heparin-induced thrombocytopenia: clinical manifestations and management strategies. Am J Med 2005; 118: 21S-30S.
8. de Pont AC, Oudemans-van Straaten HM, Roozendaal KJ, Zandstra DF. Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study. Crit Care Med 2000; 28: 421-425.
9. Hein OV, von Heymann C, Lipps M, Ziemer S, Ronco C, Neumayer HH. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy. Intensive Care Med 2001; 27: 673-679.
10. Fiaccadori E, Maggiore U, Rotelli C, Minari M, Melfa L, Cappè G, et al. Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent. Intensive Care Med 2002; 28: 586-593.
11. Oudemans-van Straaten HM, Wester JP, de Pont AC, Schetz MR. Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med 2006; 32: 188-202.
12. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients at high risk of bleeding. Kidney Int 1999; 55: 1991-1997.
13. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001; 60: 370-374.
14. Cointault O, Kamar N, Bories P, Lavayssiere L, Angles O, Rostaing L, et al. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol Dial Transplant 2004; 19: 171-178.
15. Gong D, Ji D, Xu B, Xie H, Liu Y, Li L. Regional citrate anticoagulation in critically ill patients during continuous blood purification. Chin Med J 2003; 116: 360-363.
16. Bagshaw SM, Laupland KB, Boiteau PJE, Godinez-Luna T. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 2005; 20: 155-161.
17. Morgera S, Scholle C, Voss G, Haase M, Vargas-Hein O, Krausch D, et al. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron Clin Pract 2004; 97: 131-136.
18. Kutsogiannis DJ, Gibney RTN, Stollery D, Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005; 67: 2361-2367.
19. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004; 30: 260-265.
20. Betjes MG, van Oosterom D, van Agteren M, van de Wetering J. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding. J Nephrol 2007; 20: 602-608.
21. Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011; 26: 232-239.
22. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients, a multinational, multicenter study. JAMA 2005; 294: 813-818.
23. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38: 976-981.
24. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009; 27: 545-552.
25. Joannidis M, Oudemans-van Straaten HM. Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care 2007; 11: 218.